8T0O image
Deposition Date 2023-06-01
Release Date 2024-03-27
Last Version Date 2024-10-23
Entry Detail
PDB ID:
8T0O
Keywords:
Title:
Fab from mAb RB2AT_87
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RB2AT_87 Fab Heavy chain
Chain IDs:B (auth: H)
Chain Length:217
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Molecule:RB2AT_87 Fab Light chain
Chain IDs:A (auth: L)
Chain Length:217
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Ligand Molecules
Primary Citation
Generation and Study of Antibodies against Two Triangular Trimers Derived from A beta.
Pept Sci (Hoboken) 116 ? ? (2024)
PMID: 38644932 DOI: 10.1002/pep2.24333

Abstact

Monoclonal antibodies (mAbs) that target the P-amyloid peptide (Aβ) are important Alzheimer's disease research tools and are now being used as Alzheimer's disease therapies. Conformation-specific mAbs that target oligomeric and fibrillar Aβ assemblies are of particular interest, as these assemblies are associated with Alzheimer's disease pathogenesis and progression. This paper reports the generation of rabbit mAbs against two different triangular trimers derived from Aβ. These antibodies are the first mAbs generated against Aβ oligomer mimics in which the high-resolution structures of the oligomers are known. We describe the isolation of the mAbs using single B-cell sorting of peripheral blood mononuclear cells (PBMCs) from immunized rabbits, the selectivity of the mAbs for the triangular trimers, the immunoreactivity of the mAbs with aggregated Aβ42, and the immunoreactivity of the mAbs in brain tissue from the 5xFAD Alzheimer's disease mouse model. The characterization of these mAbs against structurally defined trimers derived from Aβ enhances understanding of antibody-amyloid recognition and may benefit the development of diagnostics and immunotherapies in Alzheimer's disease.

Legend

Protein

Chemical

Disease

Primary Citation of related structures